REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.98
-0.17 (-2.09%)
Sep 23, 2026, 10:21 AM EDT - Market open
REGENXBIO Employees
REGENXBIO had 371 employees as of December 31, 2025. The number of employees increased by 18 or 5.10% compared to the previous year.
Employees
371
Change (1Y)
18
Growth (1Y)
5.10%
Revenue / Employee
$470,302
Profits / Employee
-$529,466
Market Cap
526.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | 18 | 5.10% |
| Dec 31, 2024 | 353 | 9 | 2.62% |
| Dec 31, 2023 | 344 | -57 | -14.21% |
| Dec 31, 2022 | 401 | 29 | 7.80% |
| Dec 31, 2021 | 372 | 66 | 21.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Ginkgo Bioworks Holdings | 485 |
| Arvinas | 246 |
| Capricor Therapeutics | 231 |
| ProKidney | 231 |
| Scribe Therapeutics | 82 |
| Assembly Biosciences | 73 |
| Tectonic Therapeutic | 60 |
RGNX News
- 7 days ago - REGENXBIO Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 8 days ago - REGENXBIO Transcript: 2026 Global Healthcare Conference - Transcripts
- 15 days ago - REGENXBIO to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX) - Business Wire
- 4 weeks ago - Regenxbio price target lowered to $21 from $23 at H.C. Wainwright - TheFly
- 4 weeks ago - REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli - PRNewsWire
- 4 weeks ago - Regenxbio price target lowered to $29 from $32 at Baird - TheFly
- 4 weeks ago - Regenxbio price target lowered to $32 from $45 at Clear Street - TheFly